lymph node hyperplasia: a clinicopathologic study of 16 cases.
It is also known by many other names such as angiofollicular
lymph node hyperplasia, giant lymph node hyperplasia, and angiofollicular
1) It is also known as angiofollicular
or benign giant lymph node hyperplasia.
This disease is known by other names such as angiofollicular
lymph node hyperplasia or giant lymph node hyperplasia.
1) It is rare and also known by follicular lymphoreticuloma, angiofollicular
lymph node hyperplasia, giant cell lymph node hyperplasia, benign giant lymphoma and lymphoid hamartoma.
lymph node hyperplasia in children: a clinicopathologic study of eight patients.
lymph node hyperplasia (Castleman's disease) followed by Kaposi's sarcoma in two homosexual males with the acquired immunodeficiency syndrome (AIDS).
Also called angiofollicular
or giant lymph node hyperplasia, multicentric Castleman's disease is an atypical lympho-proliferative disorder characterized by the growth of tumors in lymph node tissue.
It is a benign lymphoproliferative disease with various names like giant lymphoid hyperplasia, angiomatous lymphoid hamartoma, angiofollicular
lymphoid hyperplasia, or giant benign lymphoma (7).
INTRODUCTION: Castleman's disease (giant lymph node hyperplasia angiofollicular
lymphoid hyperplasia is a rare lymphoproliferative disease of unknown origin, first described by Castleman in 1954.
Castleman disease, also known as angiofollicular
lymph node hyperplasia, occurs in 2 forms.
Vascular endothelial growth factor is also being investigated as a contributor to the pathogenesis of hyperplastic angiofollicular
lymphoid lesions,s In addition, a chromosomal abnormality (46,XX,t(1; 16)(p11;p11),del(7)(q21q22),del(8)(q12q22)) has recently been demonstrated in dysplastic stromal cells from a case of the hyaline-vascular type, suggesting that these tumors may be in part clonal and questioning the current concept that this disease entity is best classified as a hyperplastic process.